Rutgers Researchers Receive Award to Develop First-in-Class Anticancer Therapeutics
June 01, 2020
June 01, 2020
NEW BRUNSWICK, New Jersey, June 1 -- Rutgers University issued the following news on May 27:
Rutgers cancer researchers have been awarded $200,000 to develop drugs that would eliminate cancerous tumors and prevent them for metastasizing.
Raymond B. Birge, New Jersey Medical School (NJMS), William Welsh, Robert Wood Johnson Medical School (RWJMS) and Youyi Peng, Rutgers Cancer Institute of New Jersey, received the funding from Rutgers HealthAdvance(TM), a funding platfor . . .
Rutgers cancer researchers have been awarded $200,000 to develop drugs that would eliminate cancerous tumors and prevent them for metastasizing.
Raymond B. Birge, New Jersey Medical School (NJMS), William Welsh, Robert Wood Johnson Medical School (RWJMS) and Youyi Peng, Rutgers Cancer Institute of New Jersey, received the funding from Rutgers HealthAdvance(TM), a funding platfor . . .